Fig. 2
From: SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients
Viral load among survivors and non-survivors at 6 weeks, stratified by the time between symptoms’ onset and date of sampling. For this descriptive analysis, we performed a Wilcoxon test between survivors and non-survivors. N, number of lower respiratory tract samples performed